series-c-plus
Stage
1
Investors
About
Traws Pharma is a clinical-stage biopharmaceutical company developing novel oral small molecule antiviral therapies targeting respiratory viral diseases including COVID-19, Long COVID, bird flu, and seasonal influenza.
Explore Traws Pharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.